Baseline Echocardiography and Stress Testing When Adding Amlodipine

Guideline Recommendations Against Routine Testing

The European Association of Cardiovascular Imaging and American Society of Echocardiography explicitly state that routine echocardiography to monitor antihypertensive therapy is "rarely appropriate" with a value score of only 3 out of 10, for asymptomatic patients with hypertension and dyslipidemia 1, 2

Echocardiography should be reserved for symptomatic patients, those with suspected hypertensive cardiac disease, poor blood pressure control, or abnormal ECG findings, as recommended by the European Association of Cardiovascular Imaging 1, 2, 3
Stress testing is not recommended for asymptomatic hypertensive patients due to high false-positive rates, but is indicated for patients with chest pain symptoms, abnormal or ambiguous stress ECG, according to the European Heart Journal 6, 4

Hypertensive patients are particularly prone to false-positive stress test results due to left ventricular hypertrophy, hypertensive response to stress, and subendocardial ischemia, as noted by the European Heart Journal 6, 2, 3
If echocardiography is performed, it should assess left ventricular mass and geometry, systolic and diastolic function, left atrial size, and valvular structure and function, as recommended by the European Association of Cardiovascular Imaging 1, 2, 3
Current evidence does not support using left ventricular mass measurements to initiate or modify hypertension treatment, according to the European Heart Journal 1, 2, 3

For asymptomatic patients with hypertension and dyslipidemia starting amlodipine, the European Heart Journal recommends proceeding with amlodipine without baseline testing, monitoring blood pressure response, and reassessing if symptoms develop 1, 2, 6